Signal peptide replacements enhance expression and secretion of hepatitis C virus envelope glycoproteins

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 2, 2011, Pages 96-102

  Wen, Bo ^a,b   Deng, Yao ^b   Guan, Jie ^b   Yan, Weizheng ^b   Wang, Yue ^b   Tan, Wenjie ^a,b   Gao, Jimin ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Envelope glycoprotein; Expression; Hepatitis C virus; Secretion; Signal peptide

Indexed keywords

GLYCOPROTEIN; SIGNAL PEPTIDE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; GENE EXPRESSION; GENETICS; HEPATITIS C VIRUS; HUMAN; METABOLISM; MOLECULAR GENETICS; SECRETION;

AMINO ACID SEQUENCE; CELL LINE; GENE EXPRESSION; GLYCOPROTEINS; HEPACIVIRUS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN SORTING SIGNALS; VIRAL ENVELOPE PROTEINS;

GALANTHUS NIVALIS; HEPATITIS C VIRUS; MAMMALIA;

EID: 79551506248     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq117     Document Type: Article

References (26)

1. Lindenbach BD, Thiel HJ and Rice CM. Flaviviridae: the viruses and their replication. In: Knipe DM and Howley PM eds. Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins, 2007, 1101-1152.
2. Houghton M and Abrignani S. Prospects for a vaccine against the hepatitis C virus. Nature 2005, 436: 961-966.
3. Dubuisson J. Hepatitis C virus proteins. World J Gastroenterol 2007, 13: 2406-2415.
4. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z and Murthy K, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005, 11: 791-796.
5. Lavie M, Goffard A and Dubuisson J. Assembly of a functional HCV glycoprotein heterodimer. Curr Issues Mol Biol 2007, 9: 71-86.
6. Stamataki Z, Coates S, Evans MJ, Wininger M, Crawford K, Dong C and Fong YL, et al. Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies. Vaccine 2007, 25: 7773-7784.
7. Ciczora Y, Callens N, Penin F, Pecheur EI and Dubuisson J. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1/E2 heterodimerization and involvement of these domains in virus entry. J Virol 2007, 81: 2372-2381.
8. Drummer HE, Maerz A and Poumbourios P. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 2003, 546: 385-390.
9. Falkowska E, Kajumo F, Garcia E, Reinus J and Dragic T. Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization. J Virol 2007, 81: 8072-8079.
10. Helle F, Goffard A, Morel V, Duverlie G, McKeating J, Keck ZY and Foung S, et al. The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. J Virol 2007, 81: 8101-8111.
11. Cocquerel L, Voisset C and Dubuisson J. Hepatitis C virus entry: potential receptors and their biological functions. J Gen Virol 2006, 87: 1075-1085.
12. Martoglio B and Dobberstein B. Signal sequences: more than just greasy peptides. Trends Cell Biol 1998, 8: 410-415.
13. Futatsumori-Sugai M and Tsumoto K. Signal peptide design for improving recombinant protein secretion in the baculovirus expression vector system. Biochem Biophys Res Commun 2010, 391: 931-935.
14. Zhang L, Leng Q and Mixson AJ. Alteration in the IL-2 signal peptide affects secretion of proteins in vitro and in vivo. J Gene Med 2005, 7: 354-365.
15. Li Y, Luo L, Thomas DY and Kang CY. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding. Virology 2000, 272: 417-428.
16. Bruno M, Roland G and Bernhard D. Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. EMBO J 1997, 16: 6636-6645.
17. Robert E, Oliver L, Thomas S, Markus E, Hans-Dieter K and Wolfgang G. Identification of Lassa virus glycoprotein signal peptide as a transacting maturation factor. EMBO Rep 2003, 4: 1084-1088.
18. Lobigs M, Zhao HX and Garoff H. Function of Semliki forest virus E3 peptide in virus assembly: replacement of E3 with an artificial signal peptide abolishes spike heterodimerization and surface expression of E1. J Virol 1990, 64: 4346-4355.
19. Paul AR, Mark LH, Toni W, Helen LR and Alan P. Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus K. J General Virol 1992, 73: 2737-2742.
20. Bian T, Zhou Y, Bi S, Tan W and Wang Y. HCV envelope protein function is dependent on the peptides preceding the glycoproteins. Biochem Biophys Res Commun 2009, 378: 118-122.
21. Nakai K and Horton P. PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci 1999, 24: 34-36.
22. Emanuelsson O, Brunak S, von Heijne G and Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2007, 2: 953-971.
23. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA and Bennett WF, et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983, 301: 214-221.
24. Qiu JT, Liu B, Tian C, Pavlakis GN and Yu XF. Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway. J Virol 2000, 74: 5997-6005.
25. Knappskog S, Ravneberg H, Gjerdrum C, Trösse C, Stern B and Pryme IF. The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide. J Biotechnol 2007, 128: 705-715.
26. Abraham JD, Himoudi N, Kien F, Berland JL, Codran A, Bartosch B and Baumert T, et al. Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins. Vaccine 2004, 28: 3917-3928.